Scinai Immunotherapeutics Q3 EPS $(0.02) Down From $0.06 YoY
Portfolio Pulse from Benzinga Newsdesk
Scinai Immunotherapeutics (NASDAQ:SCNI) reported Q3 losses of $(0.02) per share, a 133.33% decrease from the same period last year when it reported earnings of $0.06 per share.
October 31, 2023 | 12:25 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Scinai Immunotherapeutics reported a significant decrease in earnings per share in Q3, which could negatively impact investor sentiment.
Scinai Immunotherapeutics reported a significant decrease in earnings per share for Q3 compared to the same period last year. This is a key indicator of the company's profitability and could negatively impact investor sentiment, potentially leading to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100